Ellesmere Port, United Kingdom, March 07, 2012 --(PR.com
)-- The main focus of the Programme Office will be to support implementation and deployment of Electrans’ EMV compliant HomePay Chip&PIN solution, working with major clients throughout the region. It will also maintain Electrans’ growing number of strategic partners and key financial industry relationships.
Electrans also announced the recruitment of Alan Wilkinson as Programme Manager to head up the new office. Alan brings a wealth of financial services experience to Electrans’, including managing major operational implementations with IBM, AT&T and Royal Bank of Canada. The role is also somewhat of a homecoming for Alan, who was one of the original foundation team at Secure Electrans in 2000.
“I am extremely pleased to be rejoining at such a pivotal stage in Electrans’ development and on the eve of the launch of the HomePay product family. The programme office is ideally located to enable us to support our commercial growth strategy, and puts us within easy reach of our Issuer, Acquirer, PSPs and Utility Sector clients,” Alan commented, “We are currently in the process of recruiting experienced Project and Product Managers to support our UK implementations and to accelerate our market deployment.”
Notes to Editors
About Secure Electrans
Founded in 2000, Secure Electrans Limited is a UK based payments technology business. The Secure Electrans HomePay solution is revolutionary in its simplicity: Replicate the retail EMV Chip & PIN experience in every home. An integrated suite of bespoke web, cryptographic, analysis and payments processing services supports HomePay.
The Secure Electrans’ team comprises of some of the most experienced and respected individuals within their sector. This wealth of technical and commercial expertise alongside clear strategic objectives and patented technologies places Secure Electrans in a strong position to enable in-home and mobile Chip & PIN transactions worldwide.
For further information, please contact:
Tel: +44 (0)1926 831 262
Chris Jarman, MD
Tel: +44 (0)151 550 4888